OBJECTIVE - To delineate the epidemiology of catheter-associated urinary tract infections (CAUTIs) and to better understand the value of urine cultures for evaluation of fever in the intensive care unit (ICU) setting
DESIGN - Two-year retrospective review (2012-2013)
SETTING - A single tertiary center with 1,200 hospital beds and 158 adult ICU beds
PATIENTS - ICU patients with a CAUTI event
METHODS - The cohort was identified from a prospective infection prevention database. Charts were reviewed to characterize the patients. CAUTI rates and device utilization ratio (DUR) were calculated. Clinical outcomes were recorded.
RESULTS - A total of 105 CAUTIs were identified using the National Health and Safety Network (NHSN) definition. Fever was the primary indication for obtaining urine culture in 102 patients (97%). Of these 105 patients, 51 (51%) had an alternative infection to explain the fever, with pneumonia (55%) being the most common followed by bloodstream infection (22%). A total of 18 patients (18%) had fever due to noninfectious cause, and 32 patients (32%) had no alternative explanation. Of these, 66% received appropriate empiric antimicrobial therapy, but no targeted therapy changes were made based on urine culture results. The other 34% did not receive antimicrobial therapy at all. Only 6% of all CAUTIs resulted in blood cultures positive for the same organism within 2 days. The urinary tract was not definitely established as the source of bloodstream infection.
CONCLUSIONS - Urine cultures obtained for evaluation of fever form the basis for identification of CAUTIs in the ICU. However, most patients with CAUTIs are eventually found to have alternative explanations for fever. CAUTI is associated with a low complication rate. Infect Control Hosp Epidemiol 2015;00(0):1-5.
Infect Control Hosp Epidemiol. 2015 Jul 20:1-5. [Epub ahead of print]
Tedja R1, Wentink J2, O'Horo JC3, Thompson R3, Sampathkumar P3.
1 1Division of Critical Care Medicine,Mayo Clinic,Rochester,Minnesota.
2 3Infection Prevention and Control,Mayo Clinic,Rochester,Minnesota.
3 2Division of Infectious Disease,Mayo Clinic,Rochester,Minnesota.